Literature DB >> 7550819

Initial lesion size as a predictive factor in determining the response of port-wine stains in children treated with the pulsed dye laser.

J G Morelli1, W L Weston, J C Huff, J J Yohn.   

Abstract

OBJECTIVE: To evaluate the response of facial port-wine stains in children to pulsed (450 microseconds) dye (577- or 585-nm) laser treatment based on the age of the patient and the size of the port-wine stain at the initiation of treatments.
DESIGN: Case series.
SETTING: Outpatient dermatology clinic at the University of Colorado School of Medicine, Denver. PATIENTS: A consecutive sample of 83 children who had facial port-wine stains that were treated in their entirety at each visit. INTERVENTION: Patients were treated with a pulsed (450 microseconds) dye (577- and 585-nm) laser. MAIN OUTCOME MEASURE: Decrease in size of the port-wine stain.
RESULTS: Overall 18 (22%) of the 85 patients responded with complete clearing of their port-wine stains. The port-wine stains in 32% (7/22) of the patients who began treatment before 1 year of age responded with complete clearing of their port-wine stains compared with 18% (11/61) in older patients (P < .01). Fifteen (32%) of 47 patients with port-wine stains smaller than 20 cm2 at initial evaluation were totally cleared vs three (8%) of the 36 patients with port-wine stains larger than 20 cm2 (P < .05). This size effect is apparent at all ages.
CONCLUSION: When considering treatment for facial port-wine stains with pulsed dye lasers, it is important to consider not only the age of the child at the beginning of treatments, but also the initial size of the lesion.

Entities:  

Mesh:

Year:  1995        PMID: 7550819     DOI: 10.1001/archpedi.1995.02170230096014

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  7 in total

Review 1.  An overview of clinical and experimental treatment modalities for port wine stains.

Authors:  Jennifer K Chen; Pedram Ghasri; Guillermo Aguilar; Anne Margreet van Drooge; Albert Wolkerstorfer; Kristen M Kelly; Michal Heger
Journal:  J Am Acad Dermatol       Date:  2012-02-03       Impact factor: 11.527

2.  Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks.

Authors:  Thuy L Phung; Darryl A Oble; Wangcun Jia; Laura E Benjamin; Martin C Mihm; J Stuart Nelson
Journal:  Lasers Surg Med       Date:  2008-01       Impact factor: 4.025

3.  Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.

Authors:  Cheng-Jen Chang; Yen-Chang Hsiao; Martin C Mihm; J Stuart Nelson
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

4.  Less is more: similar efficacy in three sessions and seven sessions of pulsed dye laser treatment in infantile port-wine stain patients.

Authors:  Jiafang Zhu; Wenxin Yu; Tianyou Wang; Yijie Chen; Dongze Lyu; Lei Chang; Gang Ma; Xiaoxi Lin
Journal:  Lasers Med Sci       Date:  2018-05-10       Impact factor: 3.161

5.  [Port wine stains and Pulsed Dye Laser: study of prognostic factors in 74 Moroccan patients].

Authors:  Bouchra Baghad; Soumiya Chiheb; Hakima Benchikhi
Journal:  Pan Afr Med J       Date:  2016-12-06

6.  The Use of Neodymium-Doped Yttrium Aluminum Garnet Laser for Treatment of Hypertrophic Port-Wine Stain.

Authors:  Brittany Miles; Andrew Armenta; James Mackey
Journal:  Case Rep Dermatol Med       Date:  2022-01-25

Review 7.  Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome.

Authors:  Sara Sabeti; Karen L Ball; Craig Burkhart; Lawrence Eichenfield; Esteban Fernandez Faith; Ilona J Frieden; Roy Geronemus; Deepti Gupta; Andrew C Krakowski; Moise L Levy; Denise Metry; J Stuart Nelson; Megha M Tollefson; Kristen M Kelly
Journal:  JAMA Dermatol       Date:  2021-01-01       Impact factor: 10.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.